Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 公共衛生碩士學位學程
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64582
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor陳為堅(Wei J. Chen)
dc.contributor.authorYou-Juo Chungen
dc.contributor.author鐘友偌zh_TW
dc.date.accessioned2021-06-16T17:56:01Z-
dc.date.available2025-03-13
dc.date.copyright2020-03-13
dc.date.issued2020
dc.date.submitted2020-02-26
dc.identifier.citationAdler, A., Mounier-Jack, S., & Coker, R. J. (2009). Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care, 21(3), 284-293. doi:10.1080/09540120802183537
Antinori, A., Coenen, T., Costagiola, D., Dedes, N., Ellefson, M., Gatell, J., et al. (2011). Late presentation of HIV infection: a consensus definition. HIV Med, 12(1), 61-64. doi:10.1111/j.1468-1293.2010.00857.x
Centers for Disease Control and Prevention (2015). National HIV Prevention Progress Report, 2015. The Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services, Atlanta, Georgia.
Celesia, B. M., Castronuovo, D., Pinzone, M. R., Bellissimo, F., Mughini, M. T., Lupo, G., et al. (2013). Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. Eur Rev Med Pharmacol Sci, 17(16), 2218-2224.
Chkhartishvili, N., Chokoshvili, O., Bolokadze, N., Tsintsadze, M., Sharvadze, L., Gabunia, P., et al. (2017). Late presentation of HIV infection in the country of Georgia: 2012-2015. PLoS One, 12(10), e0186835. doi:10.1371/journal.pone.0186835
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., et al. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med, 375(9), 830-839. doi:10.1056/NEJMoa1600693
Croxford, S., Kitching, A., Desai, S., Kall, M., Edelstein, M., Skingsley, A., et al. (2017). Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. The Lancet Public Health, 2(1), e35-e46. doi:10.1016/S2468-2667(16)30020-2
Deblonde, J., De Koker, P., Hamers, F. F., Fontaine, J., Luchters, S., & Temmerman, M. (2010). Barriers to HIV testing in Europe: a systematic review. Eur J Public Health, 20(4), 422-432. doi:10.1093/eurpub/ckp231
ECDC. (2017). HIV/AIDS surveillance in Europe, 2017. Granits väg 8, SE-171 65 Solna, Sweden. Retrieved from www.ecdc.europa.eu.
Fang, C. T., Chang, Y. Y., Hsu, H. M., Twu, S. J., Chen, K. T., Lin, C. C., et al. (2007). Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM: An International Journal of Medicine, 100(2), 97-105. doi:10.1093/qjmed/hcl141
Fisher, M. (2008). Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis, 21(1), 1-3. doi:10.1097/QCO.0b013e3282f2d8fb
Hu, X., Liang, B., Zhou, C., Jiang, J., Huang, J., Ning, et al. (2019). HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study. AIDS Res Ther, 16(1), 6. doi:10.1186/s12981-019-0221-7
Huang, Y. F., Kuo, H. S., Lew-Ting, C. Y., Tian, F., Yang, C. H., Tsai, T. I., et al. (2011). Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan. Addiction, 106(8), 1437-1445. doi:10.1111/j.1360-0443.2011.03443.x
Huang, Y. C., Huang, Y. F., Lin, M. H., Yang, J. Y., Liao, Y. H., Lo, H. Y., et al. (2019). An outbreak of HIV infection among people who inject drugs linked to injection of propofol in Taiwan. PLoS One, 14(2), e0210210. doi:10.1371/journal.pone.0210210
Jeong, S. J., Italiano, C., Chaiwarith, R., Ng, O. T., Vanar, S., Jiamsakul, A., et al.( 2016). Late presentation into care of HIV disease and its associated factors in Asia: Results of TAHOD. AIDS RESEARCH AND HUMAN RETROVIRUSES, 32(3), 255-261. doi:10.1089/aid.2015.0058
Jiang, H., Yin, J., Fan, Y., Liu, J., Zhang, Z., Liu, L., & Nie, S. (2015). Gender difference in advanced HIV disease and late presentation according to European consensus definitions. Sci Rep, 5, 14543. doi:10.1038/srep14543
Krentz, H. B., Auld, M. C., & Gill, M. J. (2004). The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med, 5(2), 93-98.
Lin, K. Y., Cheng, C. Y., Li, C. W., Yang, C. J., Tsai, M. S., Liu, C. E., et al. (2017). Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PLoS One, 12(6), e0179870. doi:10.1371/journal.pone.0179870
Lo, Y. C., Wu, P. Y., Hsieh, C. Y., Chen, M. Y., Sheng, W. H., Hsieh, S. M., et al. (2011). Late diagnosis of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: role of socio-behavioral factors and medical encounters. J Formos Med Assoc, 110(5), 306-315. doi:10.1016/s0929-6646(11)60046-6
Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., Sharma, S., et al. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV Infection. N Engl J Med, 373(9), 795-807. doi:10.1056/NEJMoa1506816
Melendez, J., Reinhardt, S. W., O'Halloran, J. A., Spec, A., Alonzo Cordon, A., Powderly, W. G., & Mejia Villatoro, C. (2019). Late presentation and missed opportunities for HIV diagnosis in Guatemala. AIDS Behav, 23(4), 920-928. doi:10.1007/s10461-018-2331-y
Ministry of Health and Welfare. (2016). The sixth 5-year anti-HIV treatment and prevention program in Taiwan, 2016. Centers for Disease Control, Ministry of Health and Welfare, R.O.C.(Taiwan)
Mocroft, A., Lundgren, J. D., Sabin, M. L., Monforte, A., Brockmeyer, N., Casabona, J., et al (2013). Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med, 10(9), e1001510. doi:10.1371/journal.pmed.1001510
Sobrino-Vegas, P., Moreno, S., Rubio, R., Viciana, P., Bernardino, J. I., Blanco, J. R., et al. (2016). Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013. J Infect, 72(5), 587-596. doi:10.1016/j.jinf.2016.01.017
Taiwan Centers for Disease Control and Prevention (2014). HIV/AIDS prevention and control manual, 2014. Centers for Disease Control, Ministry of Health and Welfare, R.O.C.(Taiwan)
Taiwan Centers for Disease Control and Prevention (2019). Taiwan national infectious disease statistics system. Retrieved from: https://nidss.cdc.gov.tw/en/Default.aspx
Thanawuth, N., & Chongsuvivatwong, V. (2008). Late HIV diagnosis and delay in CD4 count measurement among HIV-infected patients in Southern Thailand. AIDS Care, 20(1), 43-50. doi:10.1080/09540120701439303
The late presenters working group in COHERE in EuroCoord (2015). Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Eurosurveillance, 20(47), 30070. doi:https://doi.org/10.2807/1560-7917.ES.2015.20.47.30070
UNAIDS (2019). UNAIDS data 2019. Retrieved from: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64582-
dc.description.abstract背景:延遲診斷的愛滋病毒感染者,容易發病為後天免疫缺乏症候群(AIDS),不僅增加醫療上的負擔,亦增加死亡率,在公共衛生的角度上,更可能增加傳染他人的機會。但是在台灣針對愛滋病毒感染者的延遲診斷定義並無一定的共識,且缺乏對於延遲診斷的愛滋病毒感染者其危險因子與預後的暸解,因此本研究目的在瞭解愛滋病毒感染者延遲診斷的趨勢、相關的危險因子,並探討其預後。
方法:利用臺灣疾病管制署傳染病通報系統,研究對象為2007至2018年間臺灣北部的愛滋病毒感染者。將使用三種延遲診斷的定義進行區分:第一,六個月延遲診斷定義為「初次診斷為愛滋病毒感染者,於診斷後六個月內,其CD4小於350 cells/μL,或不論其CD4數值,發病為AIDS」;第二,三個月延遲診斷定義為「初次診斷為愛滋病毒感染者,於診斷後三個月內,不論其CD4數值,發病為AIDS」;第三、一個月延遲診斷定義為「初次診斷為愛滋病毒感染者,於診斷後一個月內,不論其CD4數值,進展為AIDS」。以logistic regression確認與延遲診斷有關的特性,再利用survival analysis與accelerated failure time (AFT)模型估計延遲診斷之愛滋病毒感染者存活情形。
結果:本研究共納入10042名愛滋病毒感染者,符合6個月延遲診斷者共5369名(53.5%);符合3個月延遲診斷者共2722名(27.1%);符合1個月延遲診斷者共2484名(24.7%)。且研究顯示利用三種延遲診斷定義進行逐年的比較,於2011年後皆有增加的趨勢。進一步瞭解與延遲診斷有關的特性則是男性、年齡較大、異性戀、教育程度較低及失業。此外,研究亦顯示延遲診斷的愛滋病毒感染者,其存活時間為非延遲診斷者的46%。
結論:本研究確認了愛滋病毒感染者與延遲診斷有關的社會人口特徵,應針對高風險族群,制定適宜的介入政策,使早期發現、早期診斷,降低愛滋病毒感染者延遲診斷的情形。
zh_TW
dc.description.abstractBackground: Late diagnosis of infection with human immunodeficiency virus (HIV) has been associated with an increased risk of acquired immune deficiency syndrome (AIDS)-related illnesses, higher medical care costs, and increased morbidity and mortality. In public health, late diagnosis has also been associated with an increased risk of HIV transmission. However, there has been no consistent definition in reporting late diagnosis of HIV infection in Taiwan, and hence it remains little known about its factors and outcomes. This study aims to evaluate the trend, factors, and outcomes of late diagnosis of HIV infection in Northern Taiwan.
Methods: Data on persons newly diagnosed with HIV aged ≥ 18 years in Northern Taiwan between 2007 and 2018 were extracted from the National Notifiable Diseases Surveillance System of Taiwan Center of Taiwan Centers for Disease Control (Taiwan CDC). Three types of late diagnosis were evaluated in this study: 6-month late diagnosis, 3-month late diagnosis, and 1-month late diagnosis. (1) 6-month late diagnosis was defined as persons reported with a CD4 count below 350 cells/mL or an AIDS-defining event, regardless of the CD4 cell count within 6 months after HIV diagnosis; (2) 3-month late diagnosis was defined as persons reported with an AIDS-defining event within 3 months after HIV diagnosis; (3) 1-month late diagnosis was defined as presenting with an AIDS-defining event within a month after HIV diagnosis. We used multivariable logistic regression to identify factors associated with late diagnosis; Kaplan-Meier estimates to evaluate the survival probability, and accelerated failure time model to compare the relative times between the group of late diagnosis and that without late diagnosis of HIV infections, in three different definitions.
Results: Among 10042 HIV-positive persons included in this study, 5369 (53.5%) had the 6-month late diagnosis, 2,722 (27.1%) had the 3-month late diagnosis, and 2484 (24.7%) had the 1-month late diagnosis. The proportion of 6-month late diagnosis was increased from 48.8% in 2007 to 56.3% in 2018, 3-month late diagnosis was increased from 23.4% in 2007 to 32.5% in 2018, and 1-month late diagnosis was increased from 21.2% in 2007 to 30.8% in 2018. The correlates with all three definitions of late diagnosis were similar, with greater adjusted odds ratios for male sex (1.68 for the 6-month, 1.67 for the 3-month, and 1.55 for the 1-month), older age (e.g., for age  45 years versus 18-24 years being 3.42, 6.13, and 6.41, respectively), heterosexual (1.40, 1.56, and 1.47, respectively), unemployed or occupation unknown (1.30, 1.59, and 1.56, respectively), and year of HIV diagnosis later than 2009. Additionally, late diagnosis has been associated with an increased risk of all-cause deaths and AIDS-related deaths. The survival time of persons with late diagnosis as compared to that of persons without late diagnosis was 46% for the 6-month late diagnosis, and 22% for both the 3-month and 1-month late diagnosis. In addition to the late diagnosis, older age had a prominent effect on shortened survival time.
Conclusions: There was increased slightly over time in the proportion of late diagnosis among HIV-positive persons in Northern Taiwan. Late diagnosis associated sociodemographic characteristics that were identified in this study offered interventional opportunities. Therefore, the need for strategies to earlier detection of HIV infection should be highlighted, especially among the risk population.
en
dc.description.provenanceMade available in DSpace on 2021-06-16T17:56:01Z (GMT). No. of bitstreams: 1
ntu-109-R06847021-1.pdf: 2201276 bytes, checksum: a9174622bd96b46a64e79a07efa5e953 (MD5)
Previous issue date: 2020
en
dc.description.tableofcontents口試委員審定書 I
誌謝 II
中文摘要 III
Abstract IV
Contents VI
List of tables VII
List of figures VIII
Chapter 1 Introduction 1
1.1 Practicum Unit Features and Brief Introduction 1
1.2 Literature Review 2
1.3 Specific aims 6
Chapter 2 Methods 7
2.1 Data sources and study population 7
2.2 Variable definitions 8
2.3 Statistical analysis 9
Chapter 3 Results 10
3.1 Baseline characteristics and time trends in the late diagnosis of HIV 10
3.2 Baseline correlates of the late diagnosis of HIV 11
3.2 Outcomes 11
Chapter 4 Discussion 14
References 18
Supplementary Appendix 27
dc.language.isoen
dc.subject存活zh_TW
dc.subject危險因子zh_TW
dc.subject愛滋病毒感染者zh_TW
dc.subject延遲診斷zh_TW
dc.subjectHIVen
dc.subjectlate diagnosisen
dc.subjecttime trenden
dc.subjectrisk factorsen
dc.subjectmortalityen
dc.title臺灣北部愛滋病毒感染者之延遲診斷:2007至2018年之趨勢、危險因子與預後zh_TW
dc.titleLate Diagnosis among HIV-Positive Persons in Northern Taiwan: Time Trends, Risk Factors, and Outcomes, 2007-2018en
dc.typeThesis
dc.date.schoolyear108-1
dc.description.degree碩士
dc.contributor.coadvisor鄔豪欣(Hao-Hsin Wu)
dc.contributor.oralexamcommittee方啟泰(CHI-TAI FANG),黃士澤(Shih-Tse Huang)
dc.subject.keyword延遲診斷,愛滋病毒感染者,危險因子,存活,zh_TW
dc.subject.keywordHIV,late diagnosis,time trend,risk factors,mortality,en
dc.relation.page28
dc.identifier.doi10.6342/NTU202000643
dc.rights.note有償授權
dc.date.accepted2020-02-27
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept公共衛生碩士學位學程zh_TW
顯示於系所單位:公共衛生碩士學位學程

文件中的檔案:
檔案 大小格式 
ntu-109-1.pdf
  未授權公開取用
2.15 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved